Henry Schein stock holds steady as the focus stays on its dental and medical distribution model

Henry Schein (ISIN US42548G1040) is a global distributor of dental and medical products, serving offices, clinics, and laboratories through a broad supply and services network. The company trades on Nasdaq under the ticker HSIC and remains a familiar US healthcare distribution name for investors tracking defensive demand.

Business model

The company's core role is straightforward: it sources and distributes consumable supplies, equipment, and related services to healthcare providers. That makes Henry Schein a volume-and-efficiency story, where customer retention and recurring product demand matter more than one-off product cycles.

Investor angle

For investors, the structural context is more important than a single headline catalyst on a thin news day. In a sector where distribution margins are often modest, the most useful read is whether demand from dental practices and medical offices continues to support steady turnover.

Products and services

Henry Schein's product set spans dental supplies, practice-management tools, and medical consumables, with the dental distribution franchise typically the most recognizable part of the business. That mix gives the company exposure to recurring replenishment demand rather than only project-based equipment sales.

Stock context

Henry Schein shares trade on Nasdaq as HSIC. The stock is priced at $0.00 as of July 13, 2026, 9:34 a.m. ET.